Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Diener, H.C.

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(25 - 38 of 38)

Pages

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
European headache federation consensus on technical investigation for primary headache disorders
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
The International Classification of Headache Disorders, 3rd edition (beta version)
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial

Pages